NEW YORK, NY / ACCESSWIRE / May 25, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
DouYu International Holdings Limited (NASDAQ: DOYU)
Affected investors purchased DOYU stock in the initial public offering pursuant and/or traceable to the documents used by defendants to conduct that offering.
Lead Plaintiff Deadline: May 26, 2020
According to the complaint, DouYu International Holdings Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: as of the initial public offering: (i) DouYu's risks related to its top streamers had materialized, including that: (a) a top streamer was actively misrepresenting herself on DouYu's platform;and (b) costs associated with retaining top streamers was swelling; (ii) DouYu did not ensure that all of its products were fully compliant with current regulatory requirements before those products became available online; and (iii) key interactive features of DouYu's "lucky draw"were non-compliant with current regulatory requirements.
Learn about your recoverable losses in DOYU: http://www.kleinstocklaw.com/pslra-1/douyu-international-holdings-limited-loss-submission-form?id=6836&from=1
Gossamer Bio, Inc. (NASDAQ: GOSS)
The GOSS lawsuit is on behalf of investors who purchased GOSS common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer's documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline: June 2, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer's GB001 trial failures; (2) the purported clinical validation of Novartis' oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in GOSS: http://www.kleinstocklaw.com/pslra-1/gossamer-bio-inc-loss-submission-form?id=6836&from=1
Bed Bath & Beyond Inc. (NASDAQ: BBBY)
Class Period: October 2, 2019 - February 11, 2020
Lead Plaintiff Deadline: June 15, 2020
Bed Bath & Beyond Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) due to "aggressive disposition of inventory," the Company lacked sufficient inventory in key categories to support holiday sales; (2) the Company's internal control over inventory levels and financial reporting was not effective; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in BBBY: http://www.kleinstocklaw.com/pslra-1/bed-bath-beyond-inc-loss-submission-form?id=6836&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/591240/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-DOYU-GOSS-and-BBBY
